4.5 Article

Hormonal control of androgen receptor function through SIRT1

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 26, Issue 21, Pages 8122-8135

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.00289-06

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA075503, P30CA56036, R01CA75503, R01 CA093596, R01CA93596, P30 CA056036, R01 CA107382, R01 CA070896, R01CA107382, R01CA70896, R01CA86072, R01 CA086072] Funding Source: Medline
  2. NIDDK NIH HHS [1R21DK065220-01, R21 DK065220] Funding Source: Medline

Ask authors/readers for more resources

The NAD-dependent histone deacetylase Sir2 plays a key role in connecting cellular metabolism with gene silencing and aging. The androgen receptor (AR) is a ligand-regulated modular nuclear receptor governing prostate cancer cellular proliferation, differentiation, and apoptosis in response to androgens, including dihydrotestosterone (DHT). Here, SIRT1 antagonists induce endogenous AR expression and enhance DHT-mediated AR expression. SIRT1 binds and deacetylates the AR at a conserved lysine motif. Human SIRT1 (hSIRT1) repression of DHT-induced AR signaling requires the NAD-dependent catalytic function of hSIRT1 and the AR lysine residues deacetylated by SIRT1. SIRT1 inhibited coactivator-induced interactions between the AR amino and carboxyl termini. DHT-induced prostate cancer cellular contact-independent growth is also blocked by SIRT1, providing a direct functional link between the AR, which is a critical determinant of progression of human prostate cancer, and the sirtuins..

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available